Logo image of CRP.CA

CERES GLOBAL AG CORP (CRP.CA) Stock Fundamental Analysis

TSX:CRP - Toronto Stock Exchange - CA1567701091 - Common Stock - Currency: CAD

6.05  0 (0%)

Fundamental Rating

2

Overall CRP gets a fundamental rating of 2 out of 10. We evaluated CRP against 17 industry peers in the Consumer Staples Distribution & Retail industry. CRP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CRP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CRP was profitable.
CRP had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CRP reported negative net income in multiple years.
CRP had a positive operating cash flow in 4 of the past 5 years.
CRP.CA Yearly Net Income VS EBIT VS OCF VS FCFCRP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of CRP (0.66%) is worse than 64.71% of its industry peers.
With a Return On Equity value of 1.28%, CRP is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
The Return On Invested Capital of CRP (2.32%) is worse than 76.47% of its industry peers.
Industry RankSector Rank
ROA 0.66%
ROE 1.28%
ROIC 2.32%
ROA(3y)-0.67%
ROA(5y)0.64%
ROE(3y)-1.74%
ROE(5y)1.08%
ROIC(3y)N/A
ROIC(5y)N/A
CRP.CA Yearly ROA, ROE, ROICCRP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

CRP has a worse Profit Margin (0.23%) than 64.71% of its industry peers.
In the last couple of years the Profit Margin of CRP has declined.
CRP has a worse Operating Margin (0.74%) than 82.35% of its industry peers.
In the last couple of years the Operating Margin of CRP has grown nicely.
With a Gross Margin value of 2.84%, CRP is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CRP has grown nicely.
Industry RankSector Rank
OM 0.74%
PM (TTM) 0.23%
GM 2.84%
OM growth 3Y16.01%
OM growth 5YN/A
PM growth 3Y-14.08%
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y3.22%
CRP.CA Yearly Profit, Operating, Gross MarginsCRP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRP is destroying value.
The number of shares outstanding for CRP remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CRP has more shares outstanding
Compared to 1 year ago, CRP has an improved debt to assets ratio.
CRP.CA Yearly Shares OutstandingCRP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CRP.CA Yearly Total Debt VS Total AssetsCRP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CRP has an Altman-Z score of 3.63. This indicates that CRP is financially healthy and has little risk of bankruptcy at the moment.
CRP has a better Altman-Z score (3.63) than 76.47% of its industry peers.
CRP has a debt to FCF ratio of 7.70. This is a slightly negative value and a sign of low solvency as CRP would need 7.70 years to pay back of all of its debts.
CRP has a worse Debt to FCF ratio (7.70) than 64.71% of its industry peers.
CRP has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CRP (0.48) is better than 94.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.7
Altman-Z 3.63
ROIC/WACC0.17
WACC13.73%
CRP.CA Yearly LT Debt VS Equity VS FCFCRP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.54 indicates that CRP should not have too much problems paying its short term obligations.
CRP has a better Current ratio (1.54) than 82.35% of its industry peers.
A Quick Ratio of 0.47 indicates that CRP may have some problems paying its short term obligations.
The Quick ratio of CRP (0.47) is worse than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.47
CRP.CA Yearly Current Assets VS Current LiabilitesCRP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

The earnings per share for CRP have decreased strongly by -65.51% in the last year.
The Earnings Per Share has been decreasing by -7.53% on average over the past years.
The Revenue for CRP has decreased by -14.91% in the past year. This is quite bad
Measured over the past years, CRP shows a quite strong growth in Revenue. The Revenue has been growing by 15.98% on average per year.
EPS 1Y (TTM)-65.51%
EPS 3Y-7.53%
EPS 5YN/A
EPS Q2Q%-114.63%
Revenue 1Y (TTM)-14.91%
Revenue growth 3Y7.14%
Revenue growth 5Y15.98%
Sales Q2Q%-22.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRP.CA Yearly Revenue VS EstimatesCRP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 75.63, the valuation of CRP can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CRP indicates a slightly more expensive valuation: CRP is more expensive than 70.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.35, CRP is valued quite expensively.
Industry RankSector Rank
PE 75.63
Fwd PE N/A
CRP.CA Price Earnings VS Forward Price EarningsCRP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRP is valued more expensive than 82.35% of the companies in the same industry.
CRP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 14.03
EV/EBITDA 13.49
CRP.CA Per share dataCRP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CERES GLOBAL AG CORP

TSX:CRP (5/27/2025, 7:00:00 PM)

6.05

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-14 2025-05-14
Earnings (Next)09-11 2025-09-11
Inst Owners69.55%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap188.40M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 75.63
Fwd PE N/A
P/S 0.16
P/FCF 14.03
P/OCF 11.96
P/B 0.9
P/tB 0.94
EV/EBITDA 13.49
EPS(TTM)0.08
EY1.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.43
FCFY7.13%
OCF(TTM)0.51
OCFY8.36%
SpS37.18
BVpS6.7
TBVpS6.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.66%
ROE 1.28%
ROCE 3.32%
ROIC 2.32%
ROICexc 2.36%
ROICexgc 2.43%
OM 0.74%
PM (TTM) 0.23%
GM 2.84%
FCFM 1.16%
ROA(3y)-0.67%
ROA(5y)0.64%
ROE(3y)-1.74%
ROE(5y)1.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y36.03%
ROICexcg growth 5YN/A
ROICexc growth 3Y35.85%
ROICexc growth 5YN/A
OM growth 3Y16.01%
OM growth 5YN/A
PM growth 3Y-14.08%
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y3.22%
F-Score5
Asset Turnover2.89
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.7
Debt/EBITDA 5.68
Cap/Depr 26.14%
Cap/Sales 0.2%
Interest Coverage 1.29
Cash Conversion 90.01%
Profit Quality 504.38%
Current Ratio 1.54
Quick Ratio 0.47
Altman-Z 3.63
F-Score5
WACC13.73%
ROIC/WACC0.17
Cap/Depr(3y)26.77%
Cap/Depr(5y)49.33%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.51%
EPS 3Y-7.53%
EPS 5YN/A
EPS Q2Q%-114.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.91%
Revenue growth 3Y7.14%
Revenue growth 5Y15.98%
Sales Q2Q%-22.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.2%
EBIT growth 3Y24.29%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-80.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.44%
OCF growth 3YN/A
OCF growth 5YN/A